MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced today that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
News | Hypertension
FDA Recalls Quinapril Hydrochloride and Hydrochlorothiazide Tablets by Pfizer

March 23, 2022 — MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced today that Pfizer ...

Home March 23, 2022
Home
The dominant form of heart failure worldwide appears to be caused by a strong, bidirectional interaction between the body’s response to metabolic stress and the immune system, according to a review article written by UT Southwestern researchers and colleagues.
News | Heart Failure
Dominant Form of Heart Failure Caused by Metabolic-immune Interaction, Review Article Suggests
March 22, 2022 – The dominant form of heart failure worldwide appears to be caused by a strong, bidirectional ...
Home March 22, 2022
Home
Risk factors for IAE
News | Endovascular Aortic Repair
Assessing Complex Endovascular Aneurysm Repair

March 22, 2022 – A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment of ...

Home March 22, 2022
Home
A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the past is not associated with a recurrence of the condition or other serious side effects.
News | Coronavirus (COVID-19)
Study: COVID-19 Vaccination is Safe in Patients with Previous Myocarditis

March 22, 2022 — A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the ...

Home March 22, 2022
Home
A Scripps Research team developed a smartphone app that can calculate users’ genetic risk for coronary artery disease (CAD)—and found that users at high risk sought out appropriate medication after using the app.
News | Genetic Testing
Scripps Research Develops a Smartphone App to Calculate Genetic Risk for Heart Attack
March 22, 2022 – A Scripps Research team developed a smartphone app that can calculate users’ genetic risk for coronary ...
Home March 22, 2022
Home
Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC).
News | Cardiogenic Shock
Women More Likely to Die After Heart Emergency than Men

March 22, 2022 – Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to ...

Home March 22, 2022
Home
Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year compared to 94% of those with chest pain as the predominant feature. That’s the finding of research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC)
News | Heart Failure
Shortness of Breath Heralds Worse Survival than Chest Pain for Heart Attack Patients

March 22, 2022 – Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year ...

Home March 22, 2022
Home
With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and endovascular care. In addition to providing quality care to tens of thousands of patients over the years, The Cardiovascular Care Group has been committed to educating the community on vascular-related conditions through the sharing of knowledge and transparency.
News | Peripheral Artery Disease (PAD)
The Cardiovascular Care Group Raises Awareness of Peripheral Artery Disease

March 22, 2022 – With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and ...

Home March 22, 2022
Home
In an article published in Circulation Research, a leading cardiovascular research journal, a team of researchers at Loyola University Chicago Stritch School of Medicine identified a novel mechanism by which the heart functions, potentially leading to the discovery of a therapeutic to treat adults who experience heart failure. 
News | Heart Failure
Loyola University Chicago Team Identifies a Potential Therapeutic for Heart Failure Patients
March 22, 2022 – In an article published in Circulation Research, a leading cardiovascular research journal, a team of ...
Home March 22, 2022
Home
Medtronic, a global leader in healthcare technology, has announced leadership transitions for three of its Operating Units – Diabetes, Surgical Robotics, and Cardiac Rhythm Management – bringing in critical skills and capabilities and creating opportunities for internal talent.
News | Cardiovascular Business
Medtronic Appoints New Operating Unit Presidents
March 22, 2022 – Medtronic, a global leader in healthcare technology, has announced leadership transitions for three of ...
Home March 22, 2022
Home
Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, has announced it has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its wireless Agilia Connect Infusion System which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology.
News | Pharmaceuticals
Fresenius Kabi Receives FDA 510(k) Clearance for Wireless Agilia Connect Infusion System with Vigilant Software Suite-Vigilant Master Med Technology
March 22, 2022 – Fresenius Kabi, a global health care company that specializes in medicines and technologies for ...
Home March 22, 2022
Home
Sumeet Chugh, MD
News | Artificial Intelligence
Cedars-Sinai Establishes New Division: Artificial Intelligence in Medicine
March 11, 2022 – The Department of Medicine at Cedars-Sinai has established a new division to explore how artificial ...
Home March 11, 2022
Home
Zhiqiang Lin, Ph.D., Assistant Professor at the Masonic Medical Research Institute (MMRI), along with his colleagues, are actively investigating heart disease and inflammation.
News | Heart Failure
Dr. Zhiqiang Lin Awarded NIH Grant to Examine the Cardiac Innate Immune Response
March 15, 2022 – In the United States, an individual will experience a heart attack every 40 seconds. As a result of ...
Home March 11, 2022
Home
Vascepa
News | Stroke
JAHA Study: Vascepa Significantly Lowered Risk of Potentially Fatal CVD Events in Patients with Prior PCI

March 15, 2022 – Amarin has announced the publication of new REDUCE-IT data analysis that helps support the clinical ...

Home March 11, 2022
Home
Implicity
News | Remote Monitoring
Implicity Hosts US Research Competition for Free Access to Advanced AI-powered Cardiac Remote Monitoring Platform
March 15, 2022 – Implicity, a leader in AI-powered remote patient monitoring and cardiac data management solutions ...
Home March 11, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now